Geddis Amy E
Department of Pediatrics, Division of Pediatric Hematology-Oncology, University of California San Diego, La Jolla, CA, USA.
Semin Hematol. 2006 Jul;43(3):196-203. doi: 10.1053/j.seminhematol.2006.04.003.
Thrombocytopenia in the newborn period can signify an inherited platelet disorder. Congenital amegakaryocytic thrombocytopenia (CAMT) and thrombocytopenia with absent radii (TAR) share features of isolated thrombocytopenia, reduced or absent marrow megakaryocytes, impaired responsiveness to thrombopoietin (TPO), and high plasma TPO levels. These disorders are most readily distinguished from each other by the finding of radial aplasia in TAR and the presence of c-MPL mutations in CAMT. In addition, their long-term outcomes are strikingly different: the development of trilineage marrow failure in CAMT in contrast to the general improvement of thrombocytopenia in TAR. The differential diagnosis for CAMT and TAR also includes other congenital disorders in which thrombocytopenia and radial abnormalities can be seen. In this article we will review our molecular and clinical understanding of these two inherited disorders of amegakaryocytosis.
新生儿期血小板减少可能意味着遗传性血小板疾病。先天性无巨核细胞性血小板减少症(CAMT)和桡骨缺如伴血小板减少症(TAR)具有孤立性血小板减少、骨髓巨核细胞减少或缺乏、对血小板生成素(TPO)反应受损以及血浆TPO水平升高等特征。通过TAR中桡骨发育不全的表现以及CAMT中c-MPL突变的存在,最容易将这些疾病相互区分开来。此外,它们的长期预后截然不同:CAMT会发展为三系骨髓衰竭,而TAR的血小板减少情况通常会有所改善。CAMT和TAR的鉴别诊断还包括其他可见血小板减少和桡骨异常的先天性疾病。在本文中,我们将回顾对这两种遗传性无巨核细胞增多症疾病的分子和临床认识。